Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Spirituality intensification: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Graham
m reference
>Graham
m reference
(No difference)

Revision as of 12:29, 2 January 2018

Spirituality enhancement can be described as the experience of a shift in one's personal beliefs and interests. It results in one holding notions of certain key concepts with higher regard than that which they did previously.[1] These concepts and notions are not limited to but generally include:

  • An increased sense of personal purpose.[2]
  • An increased interest in the pursuit of developing personal religious and spiritual ideologies.[3][4]
    • The formation of complex personal religious beliefs.
  • An increased sense of compassion towards nature and other people.[3][4][5]
  • An increased sense of unity and interconnectedness between oneself, nature, god and the universe as a whole.[1][3][5][6][7][8]
  • A decreased sense of value placed upon finances and material objects.[5]
  • A decreased fear of death and the finite nature of existence.[1][9][10][11]

Although difficult to fully specify, these changes in one's personality and belief system can often result in profound changes in one's personality[5][7][12] which can become distinctively noticeable to others around those who undergo it. This shift can occur suddenly but will usually increase gradually over time as a person repeatedly uses the psychoactive substance which is inducing it.

Sprituality enhancement is most commonly induced under the influence of moderate dosages of psychedelics such as psilocin, ayahuasca, DMT, LSD, and mescaline. However, it can also occur less commonly under the influence of heavy doses of dissociatives and entactogens. It is worth noting that this effect is unlikely to be an independent component within itself, but is more likely to be a result of a combination of other cognitive mindstates in conjunction with a proper setting[3] which convey a wide variety of different themes. These mindsets generally include: Analysis enhancement, autonomous voice communication, novelty enhancement, perception of interdependent opposites, perception of predeterminism, perception of self-design, personal bias suppression, and unity and interconnectedness.

Analysis

There have been a number of in-depth scientific studies which unanimously support the legitimate existence of the spiritual effects induced by hallucinogen usage.[1][3][4][5][6][7][8][12] [13] [14] [15][16][17]

Frequently, new psychedelic users rate their experience to be either the single most meaningful experience of their life or among the top five most meaningful experiences of their life.[4][6][9][12]

Any psychedelic or hallucinogen intentionally used for religious or spiritual purposes is known in the literature as an entheogen.[3][18] The ritualized usage of entheogens for religious or spiritual purposes dates back thousands of years and is well established throughout both anthropological and modern evidence.[3][4][5][12][16][19]

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

Experience reports

Anecdotal reports which describe this effect within our experience index include:

See also

References

  1. 1.0 1.1 1.2 1.3 Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29(1), 57-68. https://doi.org/10.1177/0269881114555249
  2. Peterman, A. H., Fitchett, G., Brady, M. J., Hernandez, L., & Cella, D. (2002). Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy—Spiritual Well-being Scale (FACIT-Sp). Annals of behavioral medicine, 24(1), 49-58. https://doi.org/10.1207/S15324796ABM2401_06
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Trichter, S., Klimo, J., & Krippner, S. (2009). Changes in spirituality among ayahuasca ceremony novice participants. Journal of Psychoactive Drugs, 41(2), 121-134. https://doi.org/10.1080/02791072.2009.10399905
  4. 4.0 4.1 4.2 4.3 4.4 Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649-665. https://doi.org/10.1007/s00213-011-2358-5
  5. 5.0 5.1 5.2 5.3 5.4 5.5 Lerner, M., & Lyvers, M. (2006). Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study. Journal of Psychoactive Drugs, 38(2), 143-147. https://doi.org/10.1080/02791072.2006.10399838
  6. 6.0 6.1 6.2 Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268-283. https://doi.org/10.1007/s00213-006-0457-5
  7. 7.0 7.1 7.2 MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453-1461. https://doi.org/10.1177/0269881111420188
  8. 8.0 8.1 Kometer, M., Pokorny, T., Seifritz, E., & Volleinweider, F. X. (2015). Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology, 232(19), 3663-3676. https://doi.org/10.1007/s00213-015-4026-7
  9. 9.0 9.1 Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165-1180. https://doi.org/10.1177/0269881116675512
  10. Richards, W., Grof, S., Goodman, L., & Kurland, A. (1972). LSD-assisted psychotherapy and the human encounter with death. The Journal of Transpersonal Psychology, 4(2), 121. https://www.erowid.org/references/refs_view.php?ID=6424
  11. Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of general psychiatry, 68(1), 71-78. https://doi.org/10.1001/archgenpsychiatry.2010.116
  12. 12.0 12.1 12.2 12.3 Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. Journal of Psychopharmacology, 25(11), 1434-1452. https://doi.org/10.1177/0269881110382466
  13. Richards, W. A. (2008). The phenomenology and potential religious import of states of consciousness facilitated by psilocybin. Archive for the Psychology of Religion, 30(1), 189-199. https://doi.org/10.1080/02791072.2013.785855
  14. The Marsh Chapel Experiment | http://en.wikipedia.org/wiki/Marsh_Chapel_Experiment
  15. Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of psychopharmacology, 22(6), 621-632. https://doi.org/10.1177/0269881108094300
  16. 16.0 16.1 Bakalar, J. B. (1985). Social and intellectual attitudes toward drug-induced religious experience. Journal of Humanistic Psychology, 25(4), 45-66. https://doi.org/10.1177/0022167885254008
  17. Móró, L., Simon, K., Bárd, I., & Rácz, J. (2011). Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs, 43(3), 188-198. https://doi.org/10.1080/02791072.2011.605661
  18. Carl A. P. Ruck; Jeremy Bigwood; Danny Staples; Jonathan Ott; R. Gordon Wasson (January–June 1979). "Entheogens". Journal of Psychedelic Drugs. 11 (1–2): 145–146. https://doi.org/10.1080/02791072.1979.10472098
  19. Guzmán, G. (2008). Hallucinogenic mushrooms in Mexico: An overview. Economic Botany, 62(3), 404-412. https://doi.org/10.1007/s12231-008-9033-8